Pharmaceutical laboratories

After a flourishing period, the pharmaceutical industry must now face some important strategic challenges


A global market of more than a trillion dollars whose rate of growth has halved compared to the period 2005-2011, with stagnation or even a decline being felt in developed economies compared to strong growth in emerging countries.

After a flourishing period of growth, the pharmaceutical industry must now face some important strategic challenges:

  •   Increased industrial and R&D costs related to quality and approval requirements
  • Aggressiveness of public health policies (reducing reimbursements and lowering of the prices imposed, prevention, awareness, etc.)
  •    Fewer new products to be utilised
  •    Loss of patents
  • Development of generics

Most indicators are in the red: falling net income, gross margin that has continued to drop since 2006, sinking investment rate and weak production growth.

However, the market also presents opportunities: aging population, improved living standards, emergence of new diseases, etc.

The main adjustments have been made through staff costs (restructuring of the R&D functions, commercial functions, plant closures, etc.), but this merely slows the decline in performance of the operations.

For all of these reasons, industry companies are intensifying their cost restructuring and reduction policy.


KLB Group supports you in implementing your transformation projects and operational projects


Since 1998, KLB Group supports its clients in the health care industry (Big Pharma, transformers, subcontractors, suppliers, clinics) in their transformation projects and in the implementation of their operational projects, with special emphasis on purchasing, the supply chain, production, finance and commercial aspects.

Project examples


Operations Management and transformation
Supply Streamlining of ranges
Manufacture or buy Business reorganisation
Investments Industrial strategy
Purchasing projects Competitiveness program
Product development Cost reduction plan
Supplier risk management Definition of recipient organisation
Monitoring of outsourcing Assistance in the project management of information systems
Shared services in purchasing/finance/supply chain/quality Search for productivity
Skills development Implementation of shared-services centres


For each project we mobilise the entire set of experiences, knowledge, methods and tools of KLB Group.

The combination of skills and know-how is suited to each of the challenges..

During the past 10 years, we have managed around 100 projects, achieved savings worth billions of dollars for our clients and generated profits of between 5% and 10%.

Our speed of intervention, our expertise in the industry, our experts, our methods and our business model allow our customers get a return on their investment equivalent to 5-10 times the investment amount.

To respond to customer problems, we propose business models aligned with each situation: fixed price, success fees, performance-related pay, etc.

For more information in this sense:

KLB Group and the pharmaceutical industry:

64 clients

132 projets

21 experts

Billions of dollars in savings

Profits from 5 to 10%